- Home
- TOL vs HOLX Comparison
TOL vs HOLX Comparison
Compare TOL & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TOL | HOLX |
|---|---|---|
| Founded | 1967 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Medical Electronics |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.8B | 16.6B |
| IPO Year | N/A | 1990 |
Fundamental Metrics
Financial Performance| Metric | TOL | HOLX |
|---|---|---|
| Price | $139.52 | $74.98 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 15 |
| Target Price | ★ $151.60 | $79.64 |
| AVG Volume (30 Days) | 989.3K | ★ 3.0M |
| Earning Date | 12-08-2025 | 11-03-2025 |
| Dividend Yield | ★ 0.72% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 13.61 | 2.49 |
| Revenue | ★ $10,876,787,000.00 | $4,100,500,000.00 |
| Revenue This Year | $0.45 | $6.69 |
| Revenue Next Year | N/A | $5.74 |
| P/E Ratio | ★ $10.21 | $30.11 |
| Revenue Growth | ★ 3.26 | 1.74 |
| 52 Week Low | $86.67 | $51.90 |
| 52 Week High | $157.79 | $80.31 |
Technical Indicators
Market Signals| Indicator | TOL | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 56.50 | 67.93 |
| Support Level | $136.76 | $74.55 |
| Resistance Level | $145.01 | $75.12 |
| Average True Range (ATR) | 3.75 | 0.28 |
| MACD | 1.05 | -0.14 |
| Stochastic Oscillator | 71.48 | 78.92 |
Price Performance
Historical ComparisonAbout TOL Toll Brothers Inc.
Toll Brothers is the leading luxury homebuilder in the United States with an average sale price well above public competitors'. The company operates in over 60 markets across 24 states and caters to move-up, active-adult, and second-homebuyers. Traditional homebuilding operations represent most of company's revenue. Toll Brothers also builds luxury for-sale and for-rent properties in urban centers across the US. It has its headquarters in Horsham, Pennsylvania.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.